Page 84 - Vitamin D and Cancer

3 Anti-inflammatory Activity of Calcitriol in Cancer 71

126. De Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999) Proliferative inflammatory atro-
phy of the prostate: implications for prostatic carcinogenesis. Am J Pathol
155(6):1985–1992
127. Nelson WG, De Marzo AM, Isaacs WB (2003) Prostate cancer. N Engl J Med
349(4):366–381
128. De Marzo AM, DeWeese TL, Platz EA, Meeker AK, Nakayama M, Epstein JI, Isaacs WB,
Nelson WG (2004) Pathological and molecular mechanisms of prostate carcinogenesis:
implications for diagnosis, detection, prevention, and treatment. J Cell Biochem
91(3):459–477
129. Herszenyi L, Miheller P, Tulassay Z (2007) Carcinogenesis in inflammatory bowel disease.
Dig Dis 25(3):267–269
130. Itzkowitz SH, Yio X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory
bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol
287(1):G7–G17
131. Seril DN, Liao J, Yang GY, Yang CS (2003) Oxidative stress and ulcerative colitis-associated
carcinogenesis: studies in humans and animal models. Carcinogenesis 24(3):353–362
132. Tsai CJ, Cohn BA, Cirillo PM, Feldman D, Stanczyk FZ, Whittemore AS (2006) Sex steroid
hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study
in African-Americans and Caucasians (United States). Cancer Causes Control
17(10):1237–1244
133. Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Hafeli UO, Fu P, Mukhtar
H (2004) Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in
transgenic adenocarcinoma of the mouse prostate model. Cancer Res 64(9):3334–3343
134. Alagbala A, Moser MT, Johnson CS, Trump DL, Posner GH, Foster BA (2005) Prevention
of prostate cancer progression with vitamin D compounds in the transgenic adenocarcinoma
of the mouse prostate (TRAMP) model. In: Fourth annual AACR International Conference
on Frontiers in Cancer Prevention Research, 2005, Baltimore, MD, pp 107
135. Alagbala AA, Moser MT, Johnson CS, Trump DL, Posner GH, Foster BA (2006) 1a,
25-dihydroxyvitamin D3 and its analog (QW-1624F2–2) prevent prostate cancer progres-
sion. In: 13th Workshop on Vitamin D, 2006, Victoria, BC, Canada, pp 95
136. Banach-Petrosky W, Ouyang X, Gao H, Nader K, Ji Y, Suh N, DiPaola RS, Abate-Shen C
(2006) Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten
mutant mice. Clin Cancer Res 12(19):5895–5901